How does hepatic dysfunction affect drug dosing?
Liver dysfunction may not only reduce the plasma clearance of a number of drugs eliminated by biotransformation and/or biliary excretion, but it can also affect plasma protein binding which in turn could influence the processes of distribution and elimination.
What are examples of hepatotoxic medications?
Examples are chlorpromazine, halothane, isoniazid and amoxicillin-clavulanate. In early DILI research, halothane and chlorpromazine were commonly reported causes of hepatotoxicity [6].
Which drug should not be given in hepatic failure?
ACE inhibitors and nonsteroidal anti-inflammatory drugs counteract the enhanced activity of the renin-angiotensin system in advanced liver disease, thereby generating a high risk of excessive hypotension or acute renal failure, respectively. These drugs are best avoided in patients with cirrhosis.
What drugs affect liver function?
Many over-the-counter (OTC) and prescription medications can cause toxic liver disease….Prescription drugs:
- Statins.
- Antibiotics like amoxicillin-clavulanate or erythromycin.
- Arthritis drugs like methotrexate or azathioprine.
- Antifungal drugs.
- Niacin.
- Steroids.
- Allopurinol for gout.
- Antiviral drugs for HIV infection.
What is the role of the liver in drug metabolism?
Most drugs must pass through the liver, which is the primary site for drug metabolism. Once in the liver, enzymes convert prodrugs to active metabolites or convert active drugs to inactive forms. The liver’s primary mechanism for metabolizing drugs is via a specific group of cytochrome P-450 enzymes.
How does disease affect drug distribution?
The resulting modifications in the free fraction of the drug can cause a change in the volume of distribution. The distribution can also be influenced by circulatory disorders modifying local blood flows and thus impeding drug entry into the tissues. Many diseases can alter hepatic and/or renal clearance.
Why are drugs hepatotoxic?
Hepatotoxicity is the injury or liver damage caused by exposure to drugs; it is an adverse drug reaction that may be uncommon but serious. The hepatic injury can be classified into hepatocellular, cholestatic and mixed, caused by increase in alanine aminotransferase and alkaline phosphatase than upper limit of normal.
Is cefuroxime safe for liver?
Cefuroxime is a second-generation cephalosporin known to very rarely cause drug-induced liver injury (DILI).
What medications should be avoided with cirrhosis?
Other medications that should be avoided include abacavir, COX-2 inhibitors, nonsteroidal anti-inflammatory drugs, direct oral anticoagulant agents, sertraline, and tacrolimus. Herbal supplements have been shown to induce liver injury.
What medications raise ALT levels?
What medications can cause increased liver enzyme tests (AST and ALT) levels?
- aspirin,
- acetaminophen (Tylenol and others),
- ibuprofen (Advil, Motrin),
- naproxen (Naprosyn, Naprelan, Anaprox, Aleve),
- diclofenac (Voltaren, Cataflam, Voltaren-XR), and.
- phenylbutazone (Butazolidine)
When are dose adjustments indicated in the treatment of hepatic impairment?
Dosage adjustment may be needed in patient with hepatic impairment. The manufacturer recomends repeat courses should not be given until SCr < 1.5 mg/dL and/or BUN <25. Dosage adjustments may be necessary, but no specific guidelines a available. Administer 50% of dose if >2 mgdl; may increase subsequent doses in the absence of toxicities.
How are drug doses selected for drug treatment of hepatic cirrhosis?
For drugs with an intermediate hepatic extraction, initial oral doses should be chosen in the low range of normal in cirrhotic patients and maintenance doses should be reduced as for high extraction drugs. In cholestatic patients, the clearance of drugs with predominant biliary elimination may be impaired.
Is there a role for drug dose adaptation in cholestatic patients?
Dose adaptation of such drugs in cholestatic patients is, therefore, difficult and has to be performed according to pharmacological effect and/or toxicity. Importantly, the dose of drugs with predominant renal elimination may also have to be adapted in patients with liver disease.
What is the treatment for hepatic impairment in dialysis patients?
Not studied in patients with hepatic impairment; adjustment for hepatic impairment may be needed. Note: Dialysis may reduce concentrations, so the drug should be administered postdialysis Hepatic metabolism into active and inactive metabolites. Dosage adjustment may be needed in patient with hepatic impairment.